Author

Rocio Ferreiro Iglesias 1

1 University Hospital of Santiago de Compostela,Santiago de Compostela,Spain

ARE TROUGH LEVELS OF ANTI-TNF DRUGS RELATED WITH TREATMENT FAILURE AND DURATION OF TREATMENT?

Jaime González-López, Manuel Barreiro-de Acosta, Carmen Llamas, Juan Enrique Dominguez-Munoz, José María Giráldez-Montero, Rocio Ferreiro Iglesias, María Jesús Lamas-Díaz

ASSOCIATION OF BACTEROIDETES WITH ENDOSCOPIC ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)

Iria Baston-Rey, Rosa A Sueiro, Manuel Barreiro de Acosta, Laura Uribarri González, Rocio Ferreiro Iglesias, José M leiro, Juan Enrique Dominguez-Munoz

CORRELATION BETWEEN THE PRESENCE OF BACTEROIDETES AND FAECAL CALPROTECTIN FOR THE DETECTION OF ENDOSCOPIC ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Iria Baston-Rey, Rosa A Sueiro, Manuel Barreiro de Acosta, Laura Uribarri González, Rocio Ferreiro Iglesias, José M leiro, Juan Enrique Dominguez-Munoz

Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified patients on adalimumab 40 mg every week

Manuel Barreiro-de Acosta, Rocio Ferreiro Iglesias, Andrea Jardi-Cuadrado, Adriano Quiroga-Castiñeira, Iria Baston-Rey, Jaime González, Ana Sousa, Irene Zarra, Juan Enrique Dominguez-Munoz

Real life experience of first line anti-TNF in Crohn´s disease patients in Spain: do we have data to choose between infliximab and adalimumab?

Ignacio Marín-Jiménez, Guillermo Bastida, Ana Fores, Federico Argüelles-Arias, Ignacio Tagarro, Alonso Fernandez, Carmen Montoto Otero, Mariam Aguas, Rocio Ferreiro Iglesias, Olga Merino, Javier Santos Fernandez, Xavier Cortés, Francisco Mesonero Gismero, Manuel Barreiro de Acosta

THERAPEUTIC DRUG MONITORING OF INFLIXIMAB AND ADALIMUMAB FOR DETECTION OF PATIENTS AT RISK OF LOSS OF RESPONSE IN INFLAMMATORY BOWEL DISEASE.

Jaime González-López, Manuel Barreiro de Acosta, José M Giráldez-Montero, Rocio Ferreiro Iglesias, María Jesús Lamas-Díaz, Juan Enrique Dominguez-Munoz

USEFULNESS OF A MULTIDISCIPLINARY APPROACH COMBINING BOTH RHEUMATOLOGY AND GASTROENTEROLOGY FOR THE ASSESSMENT AND TREATMENT OF INFLAMMATORY BOWEL DISEASE PATIENTS

Manuel Barreiro-de Acosta, Eva Pérez-Pampín, Rocio Ferreiro Iglesias, Rafa Mejuto, Antonio Mera, Juan Enrique Dominguez-Munoz

USEFULNESS OF CONSECUTIVE FECAL CALPROTECTIN MEASUREMENTS TO PREDICT RELAPSE IN INFLAMMATORY BOWEL DISEASE PATIENTS UNDER MAINTENANCE TREATMENT WITH ANTI-TNF DRUGS.

Rocio Ferreiro Iglesias, Manuel Barreiro de Acosta, Aurelio Lorenzo-González, Juan Enrique Dominguez-Munoz

Item 1 - 8 / 8
1